Gradual dose increases are key to improving tolerability
Our experienced providers will guide you through each step, whether you choose to self-administer at home or prefer to receive your injections in our clinic
Affecting approximately 1 in 100,000 to 160,000 individuals, BBS presents as a clinically heterogeneous array of symptoms including obesity, learning impairments, retinal dystrophy, and kidney dysfunction (2)
Young says people should keep in mind that this study was done using a large dataset, which means its possible that the findings were a result of some statistical issue that couldnt be controlled for
Other common gastrointestinal effects include: Vomiting (5-24% of patients) Diarrhea (8-30% of patients) Constipation (10-24% of patients) Abdominal pain or discomfort (5-20% of patients) These side effects are typically most pronounced when initiating therapy or increasing doses, and often diminish over time as the body adjusts to the medication
The Ategenos SmartPatch platform by Ategenos Pharmaceutical is another revolutionary TDDS technology
